Literature DB >> 9696862

Analysis of functional conservation in the surface and transmembrane glycoprotein subunits of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.

A R Rosenberg1, L Delamarre, A Preira, M C Dokhélar.   

Abstract

Human T-cell leukemia virus types 1 and 2 (HTLV-1 and HTLV-2) are closely related retroviruses with nucleotide sequences that are 65% identical. To determine whether their envelope glycoproteins function similarly and to define the molecular determinants of HTLV-2 envelope-mediated functions, we have used pseudotyped viruses and have introduced mutations into regions of the HTLV-2 glycoproteins homologous to those known to be important for HTLV-1 glycoprotein functions. The envelopes of the two viruses could be exchanged with no loss of infectivity, suggesting that the glycoproteins function in broadly similar ways. However, comparative analysis of the HTLV-1 and HTLV-2 glycoproteins showed subtle differences in the structure-function relationships of the two surface glycoprotein (SU) subunits, even though they recognize the same receptor. Indeed, mutations introduced at equivalent positions in the two SU glycoproteins resulted in different phenotypes in the two viruses. The scenario is the opposite for the transmembrane glycoprotein (TM) subunits, in which the functional domains of the two viruses are strictly conserved, confirming the involvement of the TM ectodomain in postfusion events required for full infectivity of the HTLVs. Thus, although they recognize the same receptor, the HTLV-1 and HTLV-2 SU subunits have slightly different ways of transducing the conformational information that primes a common fusion mechanism effected by similar TM subunits.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696862      PMCID: PMC110017     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events.

Authors:  A R Rosenberg; L Delamarre; C Pique; D Pham; M C Dokhélar
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Atomic structure of the ectodomain from HIV-1 gp41.

Authors:  W Weissenhorn; A Dessen; S C Harrison; J J Skehel; D C Wiley
Journal:  Nature       Date:  1997-05-22       Impact factor: 49.962

3.  Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene.

Authors:  K Shimotohno; Y Takahashi; N Shimizu; T Gojobori; D W Golde; I S Chen; M Miwa; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

4.  Core structure of gp41 from the HIV envelope glycoprotein.

Authors:  D C Chan; D Fass; J M Berger; P S Kim
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

5.  Identification of a domain within the human T-cell leukemia virus type 2 envelope required for syncytium induction and replication.

Authors:  B Poon; I S Chen
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  Long terminal repeats of human T-cell leukaemia virus II genome determine target cell specificity.

Authors:  I S Chen; J McLaughlin; D W Golde
Journal:  Nature       Date:  1984 May 17-23       Impact factor: 49.962

7.  Specific adsorption of HTLV-I to various target human and animal cells.

Authors:  K Krichbaum-Stenger; B J Poiesz; P Keller; G Ehrlich; J Gavalchin; B H Davis; J L Moore
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

8.  Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system.

Authors:  R E Sutton; D R Littman
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

9.  Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.

Authors:  M Seiki; S Hattori; Y Hirayama; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Syncytium formation by recombinant HTLV-II envelope glycoprotein.

Authors:  Q X Li; D Camerini; Y Xie; M Greenwald; D R Kuritzkes; I S Chen
Journal:  Virology       Date:  1996-04-01       Impact factor: 3.616

View more
  15 in total

1.  Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.

Authors:  David Ghez; Yves Lepelletier; Sophie Lambert; Jean-Marie Fourneau; Vincent Blot; Sébastien Janvier; Bertrand Arnulf; Peter M van Endert; Nikolaus Heveker; Claudine Pique; Olivier Hermine
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  The conserved glycine-rich segment linking the N-terminal fusion peptide to the coiled coil of human T-cell leukemia virus type 1 transmembrane glycoprotein gp21 is a determinant of membrane fusion function.

Authors:  Kirilee A Wilson; Séverine Bär; Anne L Maerz; Marc Alizon; Pantelis Poumbourios
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Similar regulation of cell surface human T-cell leukemia virus type 1 (HTLV-1) surface binding proteins in cells highly and poorly transduced by HTLV-1-pseudotyped virions.

Authors:  Kathryn S Jones; Manisha Nath; Cari Petrow-Sadowski; Andrea C Baines; Megan Dambach; Ying Huang; Francis W Ruscetti
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin.

Authors:  S R Jassal; R G Pöhler; D W Brighty
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  The synthetic peptide P-197 inhibits human T-cell leukemia virus type 1 envelope-mediated syncytium formation by a mechanism that is independent of Hsc70.

Authors:  D W Brighty; S R Jassal
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.

Authors:  Kathryn S Jones; Ying K Huang; Sébastien A Chevalier; Philippe V Afonso; Cari Petrow-Sadowski; Daniel C Bertolette; Antoine Gessain; Francis W Ruscetti; Renaud Mahieux
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

Review 7.  Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.

Authors:  Kathryn S Jones; Sophie Lambert; Manuella Bouttier; Laurence Bénit; Frank W Ruscetti; Olivier Hermine; Claudine Pique
Journal:  Viruses       Date:  2011-06-15       Impact factor: 5.048

8.  Early assembly step of a retroviral envelope glycoprotein: analysis using a dominant negative assay.

Authors:  A R Rosenberg; L Delamarre; C Pique; I Le Blanc; G Griffith; M C Dokhélar
Journal:  J Cell Biol       Date:  1999-04-05       Impact factor: 10.539

9.  Molecular characterization of HTLV-1 gp46 glycoprotein from health carriers and HAM/TSP infected individuals.

Authors:  Aline C A Mota-Miranda; Fernanda K Barreto; Maria F C Amarante; Everton Batista; Joana P Monteiro-Cunha; Lourdes Farre; Bernardo Galvão-Castro; Luiz C J Alcantara
Journal:  Virol J       Date:  2013-03-06       Impact factor: 4.099

10.  HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding.

Authors:  Felix J Kim; Nicolas Manel; Edith N Garrido; Carine Valle; Marc Sitbon; Jean-Luc Battini
Journal:  Retrovirology       Date:  2004-12-02       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.